Ms LEY (Farrer—Minister for Health, Minister for Sport and Minister for Aged Care) (14:46): It is a delight to take a question from the opposition. It does not have one single health policy. I thought health was important to the Labor Party, but it does not have one single health policy. The Leader of the Opposition is skipping around the country visiting the laboratories of a listed multinational company, whose profit has increased 500 per cent since 2000, while also claiming to protect the vulnerable. My question back to the Leader of the Opposition, and back to the shadow minister for health, is: can they reassure the patients of Australia that the Medicare rebate for every single pathology item remains unchanged, and, indeed, under review with the MBS task force? Mr Dreyfus: Are you going to cut pathology tests or not? The SPEAKER: The member for Isaacs has been warned on a number of occasions. He will leave under 94(a). The member for Isaacs then left the chamber. Ms LEY: What we have said is that the bulk-billing incentive of between $1 and $3 per test, introduced by Labor to raise the rate of bulk-billing, which did not raise the rate of bulk-billing at all— Ms King interjecting— The SPEAKER: The member for Ballarat is now warned! Ms LEY: will be removed as a save. And if those listed multinational pathology companies want to claim that that will cause $30 in additional costs per test, and the Leader of the Opposition wants to believe them, then shame on him. This is a Labor Party with not one single health policy, but I remind members opposite that the sensible save that the government made in MYEFO last year allowed us to make the biggest ever listing on the PBS, which was $1 billion worth of medicines to treat hepatitis C—$1 billion worth of medicines to cure hep C within a generation. We are the only jurisdiction in the world to do that. We are a government that is running budget deficits, not budget surpluses, thanks to the mess that was left us by the Labor Party. So in taking a rational, sensible, serious approach, it made sense to remove a small bulk-billing incentive, not the Medicare rebate, and to invest in the future health of the nation.